BT-142 Orthotopic Model

Synonyms: BT142

BT-142 is a cell line derived from human glioblastoma multiforme (GBM), a highly aggressive brain cancer. It serves as a valuable tool for studying GBM pathogenesis and evaluating therapeutic approaches. BT-142 exhibits key molecular features and genetic alterations observed in GBM patients, making it a representative model for preclinical investigations. Its in vitro and in vivo behavior closely mimics the characteristics of GBM, including invasive growth, angiogenesis, and resistance to conventional treatments. Researchers utilize BT-142 to gain insights into GBM biology and to develop novel treatment strategies.

Model Details

Cancer Type: Brain Cancer
Model Name: BT-142
Mouse Strain: Nu/Nu
Treatment Data Available: N/A

BT-142 Survival

Survival of BT-142 after orthotopic intracranial injection in Nu/Nu mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content